De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Faes Farma Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Faes Farma heeft een totaal eigen vermogen van €686.0M en een totale schuld van €41.7M, wat de schuld-eigenvermogensverhouding op 6.1% brengt. De totale activa en totale passiva bedragen respectievelijk €837.5M en €151.5M. De EBIT Faes Farma is €109.3M waardoor de rentedekking 709.6 is. Het heeft contanten en kortetermijnbeleggingen van €69.8M.
Belangrijke informatie
6.1%
Verhouding schuld/eigen vermogen
€41.67m
Schuld
| Rente dekkingsratio | 709.6x |
| Contant | €69.84m |
| Aandelen | €686.01m |
| Totaal verplichtingen | €151.52m |
| Totaal activa | €837.53m |
Recente financiële gezondheidsupdates
Does Faes Farma (BME:FAE) Have A Healthy Balance Sheet?
Nov 24
Here's Why Faes Farma (BME:FAE) Can Manage Its Debt Responsibly
May 03Is Faes Farma (BME:FAE) A Risky Investment?
Aug 03Is Faes Farma (BME:FAE) Using Too Much Debt?
Mar 27Is Faes Farma (BME:FAE) A Risky Investment?
Sep 21Is Faes Farma (BME:FAE) Using Too Much Debt?
May 01Recent updates
Faes Farma, S.A. (BME:FAE) Just Released Its Full-Year Earnings: Here's What Analysts Think
Mar 01Faes Farma (BME:FAE) Is Due To Pay A Dividend Of €0.0316
Dec 18Faes Farma (BME:FAE) Will Pay A Dividend Of €0.0316
Dec 04Does Faes Farma (BME:FAE) Have A Healthy Balance Sheet?
Nov 24Here's Why Faes Farma (BME:FAE) Can Manage Its Debt Responsibly
May 03Is There An Opportunity With Faes Farma, S.A.'s (BME:FAE) 50% Undervaluation?
Sep 21Is Faes Farma (BME:FAE) A Risky Investment?
Aug 03Faes Farma (BME:FAE) Ticks All The Boxes When It Comes To Earnings Growth
Jun 17Is Faes Farma (BME:FAE) Using Too Much Debt?
Mar 27Faes Farma (BME:FAE) Is Increasing Its Dividend To €0.14
Dec 13Faes Farma's (BME:FAE) Dividend Will Be Increased To €0.17
Nov 29Is Faes Farma (BME:FAE) A Risky Investment?
Sep 21Faes Farma, S.A. (BME:FAE) Interim Results: Here's What Analysts Are Forecasting For This Year
Jul 31Is Faes Farma (BME:FAE) Using Too Much Debt?
May 01Estimating The Fair Value Of Faes Farma, S.A. (BME:FAE)
Apr 07Does Faes Farma, S.A. (BME:FAE) Have A Place In Your Dividend Portfolio?
Mar 22Faes Farma's (BME:FAE) Solid Earnings May Rest On Weak Foundations
Mar 06Faes Farma (BME:FAE) Has Compensated Shareholders With A Respectable 61% Return On Their Investment
Feb 22I Ran A Stock Scan For Earnings Growth And Faes Farma (BME:FAE) Passed With Ease
Jan 16Faes Farma (BME:FAE) Seems To Use Debt Rather Sparingly
Dec 08Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( €346.9M ) FAE } overtreffen de korte termijn passiva ( €126.6M ).
Langlopende schulden: De kortetermijnactiva FAE ( €346.9M ) overtreffen de langetermijnschulden ( €24.9M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: FAE heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van FAE is de afgelopen 5 jaar gestegen van 4% naar 6.1%.
Schuldendekking: De schuld van FAE wordt goed gedekt door de operationele kasstroom ( 253.4% ).
Rentedekking: De rentebetalingen op de schuld van FAE worden goed gedekt door EBIT ( 709.6 x dekking).